ES2098193B1 - Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea. - Google Patents
Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea.Info
- Publication number
- ES2098193B1 ES2098193B1 ES9501471A ES9501471A ES2098193B1 ES 2098193 B1 ES2098193 B1 ES 2098193B1 ES 9501471 A ES9501471 A ES 9501471A ES 9501471 A ES9501471 A ES 9501471A ES 2098193 B1 ES2098193 B1 ES 2098193B1
- Authority
- ES
- Spain
- Prior art keywords
- dehydroepiandrosterone
- percent
- topic
- pharmaceutical formulation
- new pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
NUEVA FORMULACION FARMACEUTICA DE DEHIDROEPIANDROSTERONA PARA APLICACION TOPICA PERCUTANEA. COMPRENDE: (A) 0,1 A 5 POR CIENTO EN PESO DE DEHIDROEPIANDROSTERONA; (B) 0,5-3 POR CIENTO DE UN GEL ACRILICO, 1-3 POR CIENTO DE GOMA-GUAR O 1-3 POR CIENTO DE UN GEL DERIVADO DE CELULOSA; Y OPCIONALMENTE OTROS INGREDIENTES TALES COMO GELES HIDROFILOS, ESTRADIOL, VITAMINAS, PROGESTERONA, MINOXIDIL, BASES XANTICAS, HIALURONIDASA, VASOPROTECTORES, EXTRACTOS VEGETALES, ETC. LA FORMULACION TIENE DIVERSAS APLICACIONES FARMACOLOGICAS, POR EJEMPLO, EN DESARREGLOS DEL CICLO MENSTRUAL FEMENINO, NEOPLASIAS DE MAMAS Y GINECOLOGICAS, LIPODISTROFIAS, PANICULOPATIAS Y TRASTORNOS CIRCULATORIOS, CONTUSIONES, DOLORES MUSCULARES, OBESIDAD, DIABETES, OSTEOPOROSIS, ENVEJECIMIENTO, ETC.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501471A ES2098193B1 (es) | 1995-07-21 | 1995-07-21 | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea. |
AU64196/96A AU6419696A (en) | 1995-07-21 | 1996-07-19 | Novel pharmaceutical formulation of dehydroepiandrosterone for percutaneous topical application |
PCT/ES1996/000153 WO1997003676A1 (es) | 1995-07-21 | 1996-07-19 | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501471A ES2098193B1 (es) | 1995-07-21 | 1995-07-21 | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2098193A1 ES2098193A1 (es) | 1997-04-16 |
ES2098193B1 true ES2098193B1 (es) | 1997-12-01 |
Family
ID=8291123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9501471A Expired - Fee Related ES2098193B1 (es) | 1995-07-21 | 1995-07-21 | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea. |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6419696A (es) |
ES (1) | ES2098193B1 (es) |
WO (1) | WO1997003676A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6228852B1 (en) * | 1996-07-12 | 2001-05-08 | Carolyn V. Shaak | Transdermal application of naturally occurring steroid hormones |
ES2135353B1 (es) * | 1998-03-24 | 2000-08-16 | Univ Miguel Hernandez | Utilizacion del 17beta-estradiol, sus analogos y derivados en el tratamiento de la diabetes mellitus y sus manifestaciones. |
WO1999063973A2 (en) | 1998-06-11 | 1999-12-16 | Endorecherche, Inc. | PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL |
MXPA01012769A (es) * | 1999-06-11 | 2003-06-24 | Watson Pharmaceuticals Inc | Administracion de esteroides androgenicos no orales para mujeres. |
WO2001019365A1 (en) * | 1999-09-15 | 2001-03-22 | Roche Consumer Health Ag | Pharmaceutical and/or cosmetical compositions |
FR2799645B1 (fr) * | 1999-10-13 | 2004-04-30 | Oreal | Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant |
FR2811567B1 (fr) * | 2000-07-13 | 2003-01-17 | Oreal | Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase |
FR2811563B1 (fr) * | 2000-07-13 | 2003-06-20 | Oreal | Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive, et au moins un compose augmentant la synthese des glycosaminoglycanes |
FR2811562B1 (fr) * | 2000-07-13 | 2003-03-07 | Oreal | Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide |
US7198801B2 (en) | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US7442369B1 (en) | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
FR2815858B1 (fr) * | 2000-10-26 | 2003-12-12 | Oreal | Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene |
FR2818135B1 (fr) | 2000-12-15 | 2003-02-14 | Oreal | Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide |
FR2818148B1 (fr) * | 2000-12-15 | 2005-06-24 | Oreal | Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide |
FR2818136B1 (fr) * | 2000-12-15 | 2004-10-15 | Oreal | Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un inhibiteur de no-synthase |
FR2818138B1 (fr) * | 2000-12-15 | 2003-02-14 | Oreal | Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un agent depigmentant |
AU4625901A (en) * | 2001-03-19 | 2001-10-03 | Topic Empreendimentos E Participacoes S/C Ltda. | Pharmaceutical composition of carrier substance for products based on vitamin-E,bromeline and hyaluronidase |
US7354956B2 (en) | 2002-04-12 | 2008-04-08 | L'oreal | Composition containing a sapogenin and use thereof |
FR2847475B1 (fr) * | 2002-11-25 | 2006-06-23 | Oreal | COMPOSITION COSMETIQUE OU PHARMACEUTIQUE ASSOCIANT UN AGENT MODULATEUR DE L'EXPRESSION DE L'OXYSTEROL 7alpha-HYDROXYLASE ET UN SUBSTRAT BIOLOGIQUE DE LADITE ENZYME |
EP1670433B1 (en) | 2003-10-10 | 2011-11-23 | Antares Pharma IPL AG | Transdermal pharmaceutical formulation for minimizing skin residues |
RU2275930C2 (ru) * | 2004-04-26 | 2006-05-10 | ООО "РусГен" | Композиция для коррекции возрастных изменений эндокринной системы человека (варианты) и способ получения фармацевтической формы на основе такой композиции |
WO2007124250A2 (en) | 2006-04-21 | 2007-11-01 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
US9320744B2 (en) | 2011-10-19 | 2016-04-26 | Dhea Llc | DHEA bioadhesive controlled release gel |
WO2013098592A1 (es) | 2011-12-29 | 2013-07-04 | Universidad De Chile | Anillo vaginal que comprende dhea o dhea sulfato y opcionalmente un agente modulador de la liberación del principio activo, útil para aumentar la reserva ovárica en mujeres y para aliviar síntomas asociados a la menopausia |
US11324690B2 (en) | 2019-02-12 | 2022-05-10 | Dawn Marie Cutillo | Composition for restorative vaginal lubrication and a method of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4542129A (en) * | 1982-08-16 | 1985-09-17 | Norman Orentreich | DHEA Formulations and methods for treating dry skin |
JPS60161912A (ja) * | 1984-02-01 | 1985-08-23 | Kanebo Ltd | 皮膚化粧料 |
US4628052A (en) * | 1985-05-28 | 1986-12-09 | Peat Raymond F | Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities |
ATE275957T1 (de) * | 1993-01-19 | 2004-10-15 | Endorech Inc | Therapeutische verwendungen und verabreichungsysteme von dehydroepiandrosteron |
-
1995
- 1995-07-21 ES ES9501471A patent/ES2098193B1/es not_active Expired - Fee Related
-
1996
- 1996-07-19 AU AU64196/96A patent/AU6419696A/en not_active Abandoned
- 1996-07-19 WO PCT/ES1996/000153 patent/WO1997003676A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU6419696A (en) | 1997-02-18 |
WO1997003676A1 (es) | 1997-02-06 |
ES2098193A1 (es) | 1997-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2098193B1 (es) | Nueva formulacion farmaceutica de dehidroepiandrosterona para aplicacion topica percutanea. | |
ES2159382T3 (es) | Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones. | |
PT836506E (pt) | Penso transdermico para administracao de 17-desacetil norgestimato so ou em combinacao com um estrogenio | |
ES2191979T3 (es) | Sistema de administracion de acido linoleico conjugado en preparaciones cosmeticas. | |
MX9605940A (es) | Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
BR0114927A (pt) | Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição | |
MX9302783A (es) | Composiciones rapidamente dispersables que contienen polidextrosa. | |
KR900701277A (ko) | 피임 시스템 및 방법 | |
TW429153B (en) | Aerosol compositions | |
HUP0204137A2 (hu) | Fulvesztrantot tartalmazó gyógyászati készítmény | |
DE69026496D1 (de) | Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel | |
ES2098140T3 (es) | Liosferas que contienen gonadotropina. | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
MX9501848A (es) | Nuevos compuestos polienicos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
MXPA02004933A (es) | Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides. | |
ES2174054T3 (es) | Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico. | |
ECSP941120A (es) | Derivados de 1,5 benzodiazepina | |
MY115429A (en) | Fenbendazole formulations | |
NZ237513A (en) | Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof | |
PA8449301A1 (es) | Composiciones farmaceuticas | |
DE60207693D1 (de) | Einweg-vaginalkanüle für die gleichzeitige verabreichung von arzneimitteln in verschiedener form | |
ES2038606T3 (es) | Una composicion para la preparacion extemporanea de formulaciones destinadas a aplicaciones topicas para uso farmaceutico y cosmetico. | |
SV2001000253A (es) | Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas | |
DE69803054D1 (de) | Zusammensetzung auf der basis von pflanzenextrakten und ätherischen ölen, verwendbar in therapeutika, kosmetika und diätnahrung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19970416 Kind code of ref document: A1 Effective date: 19970416 |
|
FD1A | Patent lapsed |
Effective date: 20070723 |